- Asbestos Exposure
- Consumer Fraud
- Human Rights
- Medical Devices
- Medical Drugs
- Nursing Home Abuse & Neglect
- Personal Injury & Wrongful Death
- Securities Class Actions
- Toxic Exposure
She is actively involved in two class actions against the U.S. pending in federal district court in D.C., one alleging that the IRS charged unauthorized user fees for the issuance and renewal of preparer tax identification numbers (Steele v. United States, Case No. 1:14-cv-1523-RCL), and one alleging that the Administrative Office of the U.S. Courts charges more for PACER services than is authorized by statute (Nat’l Veterans Legal Services Program v. United States, Case No. 16-745-ESH).
Meghan also spends her time on securities fraud class actions, including currently In re Technology Group, Inc. Securities Litigation, No. 15 Civ. 6369 (JFK), and in the past, cases involving Medtronic, Inc., Hospira, Inc. and several others.
She has also worked on several antitrust matters, including In re North Sea Brent Crude Oil Futures Litigation, In re Libor-Based Financial Instruments Antitrust Litigation, and generic drug cases involving “reverse payment” agreements.
Prior to joining Motley Rice, Meghan worked as a business litigation and antitrust associate in Washington, D.C. There, she assisted in the trial of a multidistrict litigation antitrust case and assisted in multiple corporate internal investigations. She is a member of Phi Beta Kappa.